Q8R314
Gene name |
Slc35f5 |
Protein name |
Solute carrier family 35 member F5 |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:74150 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8R314
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8R314-F1 | Predicted | AlphaFoldDB |
25 variants for Q8R314
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3390594089 | 76 | L>R | No | EVA | |
| rs3388495974 | 143 | A>D | No | EVA | |
| rs3388497299 | 149 | A>E | No | EVA | |
| rs3388491865 | 179 | E>D | No | EVA | |
| rs3388496356 | 179 | E>Q | No | EVA | |
| rs3388491891 | 180 | S>I | No | EVA | |
| rs3388494265 | 193 | R>H | No | EVA | |
| rs3388493714 | 207 | S>L | No | EVA | |
| rs3388493718 | 223 | V>M | No | EVA | |
| rs212480110 | 239 | T>S | No | EVA | |
| rs3388497157 | 241 | V>E | No | EVA | |
| rs3388494230 | 343 | V>I | No | EVA | |
| rs3390598383 | 345 | I>L | No | EVA | |
| rs3390538930 | 346 | V>L | No | EVA | |
| rs1133982977 | 375 | L>Q | No | EVA | |
| rs1132843477 | 376 | W>C | No | EVA | |
| rs1132227368 | 376 | W>R | No | EVA | |
| rs1135257239 | 380 | F>Y | No | EVA | |
| rs3388494202 | 419 | G>D | No | EVA | |
| rs3388493733 | 449 | V>M | No | EVA | |
| rs3388494293 | 466 | F>L | No | EVA | |
| rs3388494282 | 478 | W>* | No | EVA | |
| rs3388495416 | 486 | R>S | No | EVA | |
| rs3388497289 | 494 | R>K | No | EVA | |
| rs232496026 | 523 | A>T | No | EVA |
No associated diseases with Q8R314
1 regional properties for Q8R314
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | EamA domain | 236 - 316 | IPR000620 |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
No GO annotations of biological process
| Name | Definition |
|---|---|
| No GO annotations for biological process |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MVPPRLHRGA | GRPGGLSSLP | PFGLGSARFA | GIAFEDLREA | LATRLQMVYV | FIMNRVNSQS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| SGFSQRRRMA | LGIVILLLVD | VIWVASSELT | SYVFTQYNKP | FFSTFAKTSM | FVLYLLGFII |
| 130 | 140 | 150 | 160 | 170 | 180 |
| WKPWRQQCTR | GFRGKPAAFF | ADAEGYFAAC | TTDTSMSSSL | SEPLYVPVKF | HDLPSEKLES |
| 190 | 200 | 210 | 220 | 230 | 240 |
| TNIGTEKTPK | KSRVRFSNIM | EIRQLPSSHA | LEAKLSRMSY | PTVKDQESIL | KTVGKLTATQ |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VAKISFFFCF | VWFLANLSYQ | EALSDTQVAI | VNILSSTSGL | FTLILAAVFP | SNSGDRFTLS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| KLLAVILSIG | GVVLVNLSGS | EKSAGRDTIG | SIWSLAGAMF | YAVYIVMIKR | KVDREDKLDI |
| 370 | 380 | 390 | 400 | 410 | 420 |
| PMFFGFVGLF | NLLLLWPGFF | LLHYTGFEDF | EFPNKVVLLC | IIINGLIGTV | LSEFLWLWGC |
| 430 | 440 | 450 | 460 | 470 | 480 |
| FLTSSLIGTL | ALSLTIPLSI | IADMCMQKVQ | FSWLFFAGAI | PVFFSFFIVT | LLCHYNNWDP |
| 490 | 500 | 510 | 520 | ||
| VMVGVRRVFA | FICRKHRIQR | VPEDSEQCES | LISMHSVSQE | DGAT |